9 Meters Biopharma (FRA:2Q3A) Total Liabilities : €14.58 Mil (As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is 9 Meters Biopharma Total Liabilities?

9 Meters Biopharma's Total Liabilities for the quarter that ended in Mar. 2023 was €14.58 Mil.

9 Meters Biopharma's quarterly Total Liabilities increased from Sep. 2022 (€28.96 Mil) to Dec. 2022 (€29.03 Mil) but then declined from Dec. 2022 (€29.03 Mil) to Mar. 2023 (€14.58 Mil).

9 Meters Biopharma's annual Total Liabilities increased from Dec. 2020 (€5.77 Mil) to Dec. 2021 (€7.58 Mil) and increased from Dec. 2021 (€7.58 Mil) to Dec. 2022 (€29.03 Mil).

9 Meters Biopharma Total Liabilities Historical Data

The historical data trend for 9 Meters Biopharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

9 Meters Biopharma Total Liabilities Chart

9 Meters Biopharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

8.89

13.42

5.77

7.58

29.03

9 Meters Biopharma Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Liabilities	Get a 7-Day Free Trial															7.56	8.91	28.96	29.03	14.58

9 Meters Biopharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

9 Meters Biopharma's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	28.977	+	(0.048	+	-1.7347234759768E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	29.03

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	31.292	-	2.267
	=	29.03

9 Meters Biopharma's Total Liabilities for the quarter that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.549	+	(0.033	+	1.2490009027033E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	14.58

Total Liabilities	=	Total Assets (Q: Mar. 2023 )	-	Total Equity (Q: Mar. 2023 )
	=	8.698	-	-5.883
	=	14.58

9 Meters Biopharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of 9 Meters Biopharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

9 Meters Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 9 Meters Biopharma Inc (FRA:2Q3A) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4509 Creedmoor Road, Suite 201, Raleigh, NC, USA, 27612

Website

https://www.9meters.com

9 Meters Biopharma Inc is a clinical-stage biopharmaceutical company focused on rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs. Its products include NM-002, Larazotide, NM-003, and others.

9 Meters Biopharma Headlines

No Headlines